Tokyo Tape
Sign in
← Toho Holdings

Quarterly report · Q3

8129.TEDINET S100SULP
Period2023-04-01 → 2023-12-31
Filed2024-02-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 36
MetricValuePeriodScopeSource row
Revenue¥1.12T2023-04-01 → 2023-12-31Cons.Net sales
Revenue¥1.39T2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥1.06T2022-04-01 → 2022-12-31Cons.Net sales
Operating income¥11.6bn2023-04-01 → 2023-12-31Cons.Operating income
Operating income¥11.2bn2022-04-01 → 2022-12-31Cons.Operating income
Ordinary income¥13.6bn2023-04-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥19.2bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥13.4bn2022-04-01 → 2022-12-31Cons.Ordinary income
Profit before tax¥20.3bn2023-04-01 → 2023-12-31Cons.Income before income taxes
Profit before tax¥14.4bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)¥13.5bn2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥13.6bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥9.5bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income¥13.5bn2023-04-01 → 2023-12-31Cons.Profit loss
Net income¥9.6bn2022-04-01 → 2022-12-31Cons.Profit loss
Total assets¥804.9bnat 2023-12-31Cons.Assets
Total assets¥715.3bnat 2023-03-31Cons.Assets
Total assets¥794.4bnat 2022-12-31Cons.Total assets (5-year summary)
Total liabilities¥561.2bnat 2023-12-31Cons.Liabilities
Total liabilities¥472.4bnat 2023-03-31Cons.Liabilities
Net assets / equity¥243.7bnat 2023-12-31Cons.Net assets
Net assets / equity¥242.9bnat 2023-03-31Cons.Net assets
Net assets / equity¥240.4bnat 2022-12-31Cons.Net assets (5-year summary)
Cash and deposits¥128.9bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥86.2bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥207.252023-04-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥73.142023-10-01 → 2023-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥196.72022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥136.092022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥85.92022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥186.22023-04-01 → 2023-12-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥180.672022-04-01 → 2023-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥125.12022-04-01 → 2022-12-31Cons.Diluted earnings per share (5-year summary)
Equity ratio30.3%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio33.9%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio30.2%at 2022-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 46
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-12-31−¥44.5bn
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-12-31−¥44.5bn
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-12-31−¥2.6bn
jpcrp040300-q3r_E02608-000Dispensing Pharmacyreportable segmentrevenue2023-04-01 → 2023-12-31¥70.4bn
jpcrp040300-q3r_E02608-000Dispensing Pharmacyreportable segmentrevenue external2023-04-01 → 2023-12-31¥70.4bn
jpcrp040300-q3r_E02608-000Dispensing Pharmacyreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥9m
jpcrp040300-q3r_E02608-000Dispensing Pharmacyreportable segmentsegment profit2023-04-01 → 2023-12-31¥1.4bn
jpcrp040300-q3r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue2023-04-01 → 2023-12-31¥8.0bn
jpcrp040300-q3r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue external2023-04-01 → 2023-12-31¥1.8bn
jpcrp040300-q3r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥6.2bn
jpcrp040300-q3r_E02608-000Medical Products Manufacturing And Salesreportable segmentsegment profit2023-04-01 → 2023-12-31¥686m
jpcrp040300-q3r_E02608-000Medical Products Retailreportable segmentrevenue2023-04-01 → 2023-12-31¥1.08T
jpcrp040300-q3r_E02608-000Medical Products Retailreportable segmentrevenue external2023-04-01 → 2023-12-31¥1.04T
jpcrp040300-q3r_E02608-000Medical Products Retailreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥37.3bn
jpcrp040300-q3r_E02608-000Medical Products Retailreportable segmentsegment profit2023-04-01 → 2023-12-31¥11.8bn
jpcrp040300-q3r_E02608-000Other Related Businessreportable segmentrevenue2023-04-01 → 2023-12-31¥4.4bn
jpcrp040300-q3r_E02608-000Other Related Businessreportable segmentrevenue external2023-04-01 → 2023-12-31¥3.4bn
jpcrp040300-q3r_E02608-000Other Related Businessreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥1.0bn
jpcrp040300-q3r_E02608-000Other Related Businessreportable segmentsegment profit2023-04-01 → 2023-12-31¥258m
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-12-31¥1.16T
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-12-31¥1.12T
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-12-31¥44.5bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-12-31¥14.2bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥43.4bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥43.4bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥1.1bn
jpcrp040300-q3r_E02608-000Dispensing Pharmacyreportable segmentrevenue2022-04-01 → 2022-12-31¥68.8bn
jpcrp040300-q3r_E02608-000Dispensing Pharmacyreportable segmentrevenue external2022-04-01 → 2022-12-31¥68.8bn
jpcrp040300-q3r_E02608-000Dispensing Pharmacyreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥4m
jpcrp040300-q3r_E02608-000Dispensing Pharmacyreportable segmentsegment profit2022-04-01 → 2022-12-31¥1.7bn
jpcrp040300-q3r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue2022-04-01 → 2022-12-31¥7.4bn
jpcrp040300-q3r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue external2022-04-01 → 2022-12-31¥1.6bn
jpcrp040300-q3r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥5.8bn
jpcrp040300-q3r_E02608-000Medical Products Manufacturing And Salesreportable segmentsegment profit2022-04-01 → 2022-12-31¥715m
jpcrp040300-q3r_E02608-000Medical Products Retailreportable segmentrevenue2022-04-01 → 2022-12-31¥1.02T
jpcrp040300-q3r_E02608-000Medical Products Retailreportable segmentrevenue external2022-04-01 → 2022-12-31¥986.2bn
jpcrp040300-q3r_E02608-000Medical Products Retailreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥36.4bn
jpcrp040300-q3r_E02608-000Medical Products Retailreportable segmentsegment profit2022-04-01 → 2022-12-31¥9.4bn
jpcrp040300-q3r_E02608-000Other Related Businessreportable segmentrevenue2022-04-01 → 2022-12-31¥4.9bn
jpcrp040300-q3r_E02608-000Other Related Businessreportable segmentrevenue external2022-04-01 → 2022-12-31¥3.8bn
jpcrp040300-q3r_E02608-000Other Related Businessreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥1.2bn
jpcrp040300-q3r_E02608-000Other Related Businessreportable segmentsegment profit2022-04-01 → 2022-12-31¥449m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥1.10T
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥1.06T
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-12-31¥43.4bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥12.3bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 419
ItemContextValueUnit
Non controlling interestsPrior1YearInstant92000000JPY
Non controlling interestsCurrentQuarterInstant102000000JPY
Net assetsPrior1YearInstant242916000000JPY
Net assetsCurrentQuarterInstant243703000000JPY
Liabilities and net assetsPrior1YearInstant715288000000JPY
Liabilities and net assetsCurrentQuarterInstant804873000000JPY
Net salesPrior1YTDDuration1060433000000JPY
Net salesCurrentYTDDuration1119549000000JPY
Cost of salesPrior1YTDDuration975697000000JPY
Cost of salesCurrentYTDDuration1033049000000JPY
Gross profitPrior1YTDDuration84736000000JPY
Gross profitCurrentYTDDuration86500000000JPY
Directors compensations salaries and allowances sgaPrior1YTDDuration33390000000JPY
Directors compensations salaries and allowances sgaCurrentYTDDuration33500000000JPY
Provision for bonuses sgaPrior1YTDDuration1546000000JPY
Provision for bonuses sgaCurrentYTDDuration1608000000JPY
Provision for directors bonuses sgaPrior1YTDDuration31000000JPY
Provision for directors bonuses sgaCurrentYTDDuration32000000JPY
Retirement benefit expenses sgaPrior1YTDDuration210000000JPY
Retirement benefit expenses sgaCurrentYTDDuration213000000JPY
Welfare expenses sgaPrior1YTDDuration5849000000JPY
Welfare expenses sgaCurrentYTDDuration5832000000JPY
Vehicle expenses sgaPrior1YTDDuration824000000JPY
Vehicle expenses sgaCurrentYTDDuration784000000JPY
Provision of allowance for doubtful accounts sgaPrior1YTDDuration325000000JPY
Provision of allowance for doubtful accounts sgaCurrentYTDDuration-156000000JPY
Depreciation sgaPrior1YTDDuration4150000000JPY
Depreciation sgaCurrentYTDDuration4414000000JPY
Amortization of goodwill sgaPrior1YTDDuration222000000JPY
Amortization of goodwill sgaCurrentYTDDuration202000000JPY
Rent expenses sgaPrior1YTDDuration5986000000JPY
Rent expenses sgaCurrentYTDDuration6304000000JPY
Taxes and dues sgaPrior1YTDDuration1565000000JPY
Taxes and dues sgaCurrentYTDDuration1630000000JPY
Exepences before deduction of temporary consumption tax payment sgaPrior1YTDDuration4810000000JPY
Exepences before deduction of temporary consumption tax payment sgaCurrentYTDDuration5013000000JPY
Other sgaPrior1YTDDuration14648000000JPY
Other sgaCurrentYTDDuration15537000000JPY
Selling general and administrative expensesPrior1YTDDuration73564000000JPY
Selling general and administrative expensesCurrentYTDDuration74918000000JPY
Operating incomePrior1YTDDuration11172000000JPY
Operating incomeCurrentYTDDuration11581000000JPY
Interest income noiPrior1YTDDuration41000000JPY
Interest income noiCurrentYTDDuration40000000JPY
Dividends income noiPrior1YTDDuration1048000000JPY
Dividends income noiCurrentYTDDuration945000000JPY
Equity in earnings of affiliates noiPrior1YTDDuration132000000JPY
Equity in earnings of affiliates noiCurrentYTDDuration313000000JPY
Real estate rent noiPrior1YTDDuration624000000JPY
Real estate rent noiCurrentYTDDuration633000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-04-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass